American Coronavirus Vaccine Prepared for Final Test. Fauci: ‘No matter how you slice it, this is good news’

In March, a COVID-19 vaccine was tested by National Health and Modern Inc. Phase I trials conducted on Tuesday by Inc., on 45 healthy adults, reported that all participants in the study reflected an immune system boost response, testing it on 30,000 participants starting July 27 To begin enabling vaccine testing institutions, which will make it the world’s largest study.

Results in the study were drawn from younger subjects; Results of older adults are currently being analyzed.

“Those early volunteers have developed what are called antibodies that neutralize antibodies in their bloodstream – the molecules are important to prevent infection – at levels comparable to survivors of COVID-19, the research team reported in the New England Journal Told in off medicine. “

Leader of the study, Dr. Kaiser Permanente Washington Research Institute in Seattle. Lisa Jackson claimed, “This is an essential building block that needs to proceed with tests that can actually determine if the vaccine protects against infection.”

The study in the New England Journal of Medicine reported that scientists conducted “a phase 1, dose-escalation, open-label trial involving 45 healthy adults, people between 18 and 55 years of age, who took two days 28 days apart Vaccinations were received … 15 participants in each dose group … After the first vaccination, antibody responses were higher with higher doses. After the second vaccination, titers increased. After the second vaccination, all participants evaluated Serum-neutralizing activity was detected in two ways … Decreased adverse events occurring in more than half of the participants included tiredness, chills, headaches, myalgia, and pain at the injection site. Systemic adverse events after the second vaccination. Were more common, especially with the highest dose, and three participants in the 250-μg dose group reported one or more serious adverse events. “

The study concluded, “The mRNA-1273 vaccine induced SARS-CoV-2 immune responses in all participants, and no trial-limiting safety concerns were identified.”

The future vaccine will be given twice; First time after a month

Dr. of Vanderbilt University Medical Center. William Scheffner described the mild side effects as “the small price to pay for protection against COVID.” He called the results obtained from the study “a good first step”, and said that the final test could reveal a vaccine ready to begin as early as 2021, although he warned, “It would be amazing.” But it feels right to do everything on time. “

In mid-May, The Daily Wire reported, “Modern’s team conducted a phase 1 trial on eight people, given each dose of the vaccine, and tested whether vaccine recipients developed a natural immunity to coronovirus. The researchers stated that all participants tested positive for antibodies against coronovirus 15 days after their first dose.

Dr. Anthony Fauci said on Tuesday that people think “this is a winner’s race. Me, I am cheering every one of them. We need many vaccines. We are not only for our country, but the world.” Needs vaccines. He concluded, “No matter how you cut it, that’s good news.”

The Daily Wire is one of America’s fastest growing conservative media companies and counter-cultural outlets for news, opinion and entertainment. Enter the daily wire Member.